COVID-19SERIES OF
WEBINARS https://covid19.ser.es/
Sponsored by:
ScientificCommittee
www.ser.es
Miguel Ángel Abad HernándezHospital Virgen del Puerto, Cáceres, Spain
José Mª Álvaro-Gracia Álvaro President of Spanish Society of Rheumatology.Hospital General Universitario Gregorio Marañón, Madrid, Spain
Loreto Carmona OrtellsInstituto de Salud Musculoesquelética, Madrid, Spain
Ramón Mazzucchelli EstebanHospital Universitario Fundación Alcorcón, Madrid, Spain Raimon Sanmartí SalaHospital Universitario Clínic de Barcelona, Spain
https://covid19.ser.es/
COVID-19SERIES OF
WEBINARS
THURSDAY 11TH JUNE | 16.30-18.20 H WEBINAR. COVID-19: AN OVERVIEW
TUESDAY 16TH JUNE | 16.30-18.10 H WEBINAR. COVID-19: CLINICAL
MANIFESTATIONS16.30-16.35 h Introduction
José Mª Álvaro-GraciaPresident of Spanish Society of Rheumatology.Hospital General Universitario Gregorio Marañón, Madrid, Spain
16.35-16.50 h SARS-CoV-2: the virusAna Fernández-Sesma Icahn School of Medicine at Mount Sinai, New York, USA
16.50-17.05 h COVID-19. Hopes on therapy?Adolfo García-SastreGlobal Health and Emerging Pathogens Institute. Icahn School of Medicineat Mount Sinai, New York, USA
17.05-17.20 h Discussion
17.20-17.35 h Physiopathology of SARS-CoV-2 infectionBin CaoChina-Japan Friendship Hospital, Beijing, China
17.35-17.50 h Hypercoagulability in COVID-19Jean M. ConnorsBrigham and Women's Hospital. Harvard Medical School, Boston, USA
17.50-18.05 h Diagnosis of COVID-19. What test and what for? Jordi Vila Hospital Universitario Clínic de Barcelona, Spain
18.05-18.20 h Discussion
16.30-16.35 h IntroductionMª José Cuadrado Clínica Universidad de Navarra, Madrid, Spain
16.35-16.50 h Clinical manifestations and poor prognosis factors in COVID-19
Alex SorianoHospital Universitario Clínic de Barcelona. Universitat de Barcelona-IDIBAPS,Barcelona, Spain
16.50-17.05 h COVID-19 and the heartMarco MetraUniversità degli Studi di Brescia, Brescia, Italy
17.05-17.15 h Skin manifestations of COVID-19 infectionIgnacio García-DovalComplejo Hospitalario Universitario de Pontevedra, Spain
17.15-17.25 h Neurological manifestations of COVID-19 infection David García-AzorínHospital Clínico Universitario de Valladolid, Spain
17.25-17.35 h Kidney involvement in COVID-19 Almudena VegaHospital General Universitario Gregorio Marañón, Madrid, Spain
17.35-17.50 h Use of renin-angiotensin inhibitors and risk of COVID19Francisco de AbajoHospital Universitario Príncipe de Asturias. Universidad de Alcalá, Madrid, Spain
17.50-18.10 h Discussion
Chair:
José Mª Álvaro-GraciaChair:
Mª José Cuadrado
https://covid19.ser.es/https://covid19.ser.es/
Chair:
Loreto Carmona
TUESDAY 23RD JUNE | 16.30-18.10 H WEBINAR. COVID-19:
IN SEARCH OF THERAPY16.30-16.35 h Introduction
Loreto Carmona Instituto de Salud Musculoesquelética, Madrid, Spain
16.35-16.50 h A matter of curves Aurelio Tobías Instituto de Evaluación Ambiental e Investigación del Agua (IDAEA).Consejo Superior de Investigaciones Científicas (CSIC), Barcelona, Spain
16.50-17.05 h How to control a pandemic Helena Legido-Quigley Saw Swee Hock School of Public Health. National University of Singapore
17.05-17.35 h Vaccines17.05-17.15 h Mariano Esteban Consejo Superior de Investigaciones Científicas (CSIC) y Centro Nacional de Biotecnología (CNB), Madrid, Spain
17.15-17.25 h Luis Enjuanes Consejo Superior de Investigaciones Científicas (CSIC) y Centro Nacional de Biotecnología (CNB), Madrid, Spain
17.25-17.35 h Adrian Hill The Jenner Institute. University of Oxford, UK
17.35-17.45 h Chemoprophylaxis (colchicine, antimalarials and antivirals)
Bonaventura ClotetHospital Universitario Germans Trias i Pujol, Barcelona, Spain
17.45-17.55 h Availability of vaccines in the worldDavid M. Salisbury Royal Institute of International Affairs, Chatham House, London, UK
17.55-18.15 h Discussion
16.30-16.35 h IntroductionRaimon SanmartíHospital Universitario Clínic de Barcelona, Spain
16.35-16.50 h Searching for targets in artificial intelligence timeJustin Stebbing Imperial College, London, UK
16.50-17.00 h Role of antivirals (remdesivir, lopinavir-ritonavir interferon)
José M. Miró Hospital Universitario Clínic de Barcelona, Spain
17.00-17.10 h Antimalarials in SARS-CoV-2 infection
Saint-Antoine Hospital, Paris, France
17.10-17.20 h More randomized control trials, pleaseCésar Hernández Agencia Española del Medicamento, Madrid, Spain
17.20-17.35 h Role of biological agents in the treatment of COVID-19 Carlo Salvarani University of Modena and Reggio Emilia, Modena, Italy
17.35-17.50 h Non-biological anti-inflammatory agents in the treatment of COVID-19
Fabrizio Cantini Nuovo Ospedale di Prato - Presidio "Misericordia e Dolce", Prato, Italy
17.50-18.10 h Discussion
Chair:
Raimon Sanmartí
THURSDAY 18TH JUNE | 16.30-18.15 H WEBINAR. COVID-19: EPIDEMIOLOGY AND PREVENTION
https://covid19.ser.es/ https://covid19.ser.es/
Francis Berenbaum
THURSDAY 25TH JUNE | 16.30-18.10 H WEBINAR. COVID-19:IN RHEUMATOLOGY
Juan J. Gómez-Reino
16.30-16.35 h IntroductionJuan J. Gómez-ReinoFundación Ramón Domínguez. Hospital Clínico Universitario de Santiago, Spain
16.35-16.50 h Risk of COVID-19 in rheumatic diseasesJosé Luis Pablos Hospital Universitario 12 de Octubre, Madrid, Spain
16.50-17.05 h COVID-19 Global Rheumatology Alliance. Evolution of rheumatic patients with COVID-19 Pedro Machado University College London, UK
17.05-17.20 h Managing rheumatic patients in COVID-19 times José Mª Álvaro-GraciaPresident of Spanish Society of Rheumatology.Hospital General Universitario Gregorio Marañón, Madrid, Spain
17.20-17.35 h The impact of COVID-19 in rheumatology. An opportunity for change?Iain B McInnes
https://covid19.ser.es/
COVID-19SERIES OF
WEBINARS
17.35-17.50 h No more pandemics, thank youPedro AlonsoWorld Health Organization's World Malaria Programme, Geneva, Switzerland
17.50-18.10 h Discussion
EULAR PresidentInstitute of Infection, Immunity and Inflammation. University of Glasgow, UK
Chair:
www.ser.es
https://covid19.ser.es/
Sponsored by:
Top Related